The Value of Antiangiogenics in Breast Cancer Therapy
Standard
The Value of Antiangiogenics in Breast Cancer Therapy. / Banys-Paluchowski, Malgorzata; Fehm, Tanja; Muller , Volkmar .
Tumor Angiogenesis. ed. / Dieter Marmé. 1. ed. Springer, 2017. p. 1-13.Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Research › peer-review
Harvard
Banys-Paluchowski, M, Fehm, T & Muller , V 2017, The Value of Antiangiogenics in Breast Cancer Therapy. in D Marmé (ed.), Tumor Angiogenesis. 1 edn, Springer, pp. 1-13. https://doi.org/10.1007/978-3-319-31215-6_24-1
APA
Banys-Paluchowski, M., Fehm, T., & Muller , V. (2017). The Value of Antiangiogenics in Breast Cancer Therapy. In D. Marmé (Ed.), Tumor Angiogenesis (1 ed., pp. 1-13). Springer. https://doi.org/10.1007/978-3-319-31215-6_24-1
Vancouver
Banys-Paluchowski M, Fehm T, Muller V. The Value of Antiangiogenics in Breast Cancer Therapy. In Marmé D, editor, Tumor Angiogenesis. 1 ed. Springer. 2017. p. 1-13 https://doi.org/10.1007/978-3-319-31215-6_24-1
Bibtex
@inbook{b0256859a6cf40d09d7273e21f51f024,
title = "The Value of Antiangiogenics in Breast Cancer Therapy",
author = "Malgorzata Banys-Paluchowski and Tanja Fehm and Volkmar Muller",
year = "2017",
doi = "10.1007/978-3-319-31215-6_24-1",
language = "English",
isbn = "978-3-319-31215-6",
pages = "1--13",
editor = "Dieter Marm{\'e}",
booktitle = "Tumor Angiogenesis",
publisher = "Springer",
address = "Germany",
edition = "1",
}
RIS
TY - CHAP
T1 - The Value of Antiangiogenics in Breast Cancer Therapy
AU - Banys-Paluchowski, Malgorzata
AU - Fehm, Tanja
AU - Muller , Volkmar
PY - 2017
Y1 - 2017
U2 - 10.1007/978-3-319-31215-6_24-1
DO - 10.1007/978-3-319-31215-6_24-1
M3 - SCORING: Contribution to collected editions/anthologies
SN - 978-3-319-31215-6
SP - 1
EP - 13
BT - Tumor Angiogenesis
A2 - Marmé, Dieter
PB - Springer
ER -
